Table 3

Levels of evidence for a causal effect of patient activation (PAct) on T2D-related clinical outcomes

OutcomeEvidence for PAct scoresDescription
HbA1c/glycaemic controlModerate evidence of favourable association
  • 14 studies reported on the association between HbA1c and PAct scores.6 18 48–51 62 64–66 68–70 72

  • This included two large high-quality studies with moderate design,49 51 one large high-quality cross-sectional study18 and one small high-quality cross-sectional study that reported lower HbA1c levels with higher PAct scores.66

  • One large high-quality study with moderate design50 and two large high-quality cross-sectional studies65 72 reported no association between HbA1c and PAct scores.

    • Moderate evidence that higher PAct scores are associated with better HbA1c values because two out of three high-quality studies with moderate designs and large sample sizes reported this finding.49 51

Blood pressureInconclusive
  • All four studies reported no association between blood pressure and PAct scores6 48 62 72 and had uniformly weak designs

  • Only one was high-quality.72

    • Inconclusive evidence

Low-density lipoprotein (LDL)Inconclusive
  • Only one study high-quality study with a weak design assessed the association between LDL and PAct scores and reported no association.72

    • Inconclusive evidence

High-density lipoprotein (HDL)No evidence
  • No studies reported on the association between HDL and PAct scores.

Total cholesterol and serum triglyceridesVery limited evidence of no association
  • Three studies evaluated the association between total cholesterol and serum triglycerides with PAct scores,48 50 62 all reported no association.

  • The only high-quality study had a moderate design and large sample size,50 while the remaining studies were low-quality and had weak designs, including one with a large sample size.62

    • Very limited evidence that PAct has no association with total cholesterol and serum triglycerides.

Body mass index (BMI)Inconclusive
  • Four high-quality studies reported lower BMI with increased PAct scores,49 65 66 74 three of which had large sample sizes,49 65 74 including one with a moderate design49 and the rest with weak designs.65 66 74

  • One large low-quality study with moderate design reported lower BMI with high PAct scores.63

  • Two other high-quality studies, one large with a weak design,72 and one large study with a moderate design50 found no association between PAct scores and BMI.

    • Inconclusive evidence because both the large high-quality studies with moderate designs49 50 are not in agreement.

Body weightInconclusive
  • Only one large high-quality study with moderate design reported a lower body weight with higher PAct scores.49

    • Inconclusive evidence

  • HbA1c, glycated haemoglobin; PAct, Patient activation; T2D, type 2 diabetes.